Daghero, H.; Fernández Massó, J.R.; Astrada, S.; Guerra Vallespí, M.; Bollati-Fogolín, M.
The Anticancer Peptide CIGB-552 Exerts Anti-Inflammatory and Anti-Angiogenic Effects through COMMD1. Molecules 2021, 26, 152.
https://doi.org/10.3390/molecules26010152
AMA Style
Daghero H, Fernández Massó JR, Astrada S, Guerra Vallespí M, Bollati-Fogolín M.
The Anticancer Peptide CIGB-552 Exerts Anti-Inflammatory and Anti-Angiogenic Effects through COMMD1. Molecules. 2021; 26(1):152.
https://doi.org/10.3390/molecules26010152
Chicago/Turabian Style
Daghero, Hellen, Julio Raúl Fernández Massó, Soledad Astrada, Maribel Guerra Vallespí, and Mariela Bollati-Fogolín.
2021. "The Anticancer Peptide CIGB-552 Exerts Anti-Inflammatory and Anti-Angiogenic Effects through COMMD1" Molecules 26, no. 1: 152.
https://doi.org/10.3390/molecules26010152
APA Style
Daghero, H., Fernández Massó, J. R., Astrada, S., Guerra Vallespí, M., & Bollati-Fogolín, M.
(2021). The Anticancer Peptide CIGB-552 Exerts Anti-Inflammatory and Anti-Angiogenic Effects through COMMD1. Molecules, 26(1), 152.
https://doi.org/10.3390/molecules26010152